- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Stellence Pharmscience Private Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (5), financial health (50), director (55) and company-foundation signals.
- Operating for 34+ years.
- Company status is "Under Cirp" (not Active).
- Last balance sheet filed for Mar 2022 - filings look overdue.
- Loss-making in FY 2022.
- Positive net worth.
- 6 directors on the board.
- Director LALIT KUMAR YADAV has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U85110KA1992PTC012673). Business overview includes Pharma (API Manufacturers), incorporated on January 01, 1992 (34+ years old), headquartered in Bangalore, Karnataka, India. The company is currently Under Cirp with Active Compliant compliance status.
- Location No.456, 1A And 1B Industrial Area Jigani, Bangalore, Karnataka - 562106
- Website stellencepharmscience.com
Financial Performance of Stellence Pharmscience Private Limited
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Stellence Pharmscience Private Limited (6)
Charges of Stellence Pharmscience Private Limited
| Lender | Amount | Status |
|---|---|---|
|
Tata Capital Financial Services Limited
Creation Date: 30 Jun 2017 |
7.50 cr | Open |
|
Religare Finvest Limited
Creation Date: 28 Jul 2015 |
4.00 cr | Open |
|
Religare Finvest Limited
Creation Date: 28 Jul 2015 |
4.00 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
